ArriVent BioPharma Inc [AVBP] stock prices are up 3.53% to $22.00 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AVBP shares have gain 7.84% over the last week, with a monthly amount glided 4.36%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ArriVent BioPharma Inc [NASDAQ: AVBP] stock has seen the most recent analyst activity on March 20, 2025, when B. Riley Securities initiated its Buy rating and assigned the stock a price target of $37. Previously, Guggenheim started tracking the stock with Buy rating on March 10, 2025, and set its price target to $45. On July 22, 2024, Oppenheimer initiated with a Outperform rating and assigned a price target of $35 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $25 on April 30, 2024. Jefferies initiated its recommendation with a Buy and recommended $35 as its price target on February 20, 2024. Goldman started tracking with a Buy rating for this stock on February 20, 2024, and assigned it a price target of $27. In a note dated February 20, 2024, Citigroup initiated an Buy rating and provided a target price of $30 on this stock.
The stock price of ArriVent BioPharma Inc [AVBP] has been fluctuating between $15.47 and $36.37 over the past year. Currently, Wall Street analysts expect the stock to reach $35.67 within the next 12 months. ArriVent BioPharma Inc [NASDAQ: AVBP] shares were valued at $22.00 at the most recent close of the market. An investor can expect a potential return of 62.14% based on the average AVBP price forecast.
Analyzing the AVBP fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.59, Equity is -0.49 and Total Capital is -0.36. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 21.20 points at the first support level, and at 20.40 for the second support level. However, for the 1st resistance point, the stock is sitting at 22.61, and for the 2nd resistance point, it is at 23.22.
Ratios To Look Out For
It’s worth pointing out that ArriVent BioPharma Inc [NASDAQ:AVBP]’s Current Ratio is 14.34. As well, the Quick Ratio is 14.34, while the Cash Ratio is 3.85.
